Table 2. Number of new patients discussed in each tumour site-specific MDM, their cost per month and cost per case.
MDM | No. of new patients referred/discussed | Cost per MDM (£) | Cost per case (£) |
---|---|---|---|
Gynaecology |
60 (10.9%) |
8490 |
141 |
Renal |
13 (2.4%) |
2192 |
168 |
Melanoma |
21 (3.8%) |
3912 |
186 |
Lung |
31 (5.6%) |
4047 |
130 |
Head and neck/thyroid |
56 (10.2%) |
7124 |
127 |
Sarcoma |
66 (12.0%) |
8079 |
122 |
Lymphoma |
22 (4.0%) |
6930 |
315 |
Colorectal 1 |
10 (1.8%) |
5161 |
516 |
Colorectal 2 |
18 (3.3%) |
4824 |
268 |
Breasta |
44 (8.0%) |
5112 |
116 |
Breastb |
73 (13.2%) |
7656 |
105 |
Urologya |
42 (7.6%) |
4364 |
104 |
Urologyb |
41(7.4%) |
2917 |
71 |
Upper gastrointestinal and hepatobiliary tract |
54 (9.8%) |
10 050 |
186 |
Total | 551 (100%) | 80 858 |
Abbreviation: MDM=multidisciplinary team meeting.
Chelsea branch.
Sutton branch.